Advertisement

CHAPEL HILL, N.C., Sept. 7, 2012 /PRNewswire/ -- Medical device organizations with a presence in emerging markets are consistently reporting double-digit revenue growth in their quarterly and annual reports. As part of their expansion into emerging markets, device companies are conducting more and more clinical trials in these high-growth countries. Some companies are using CROs, others are establishing small beach-head offices and using local resources while some are spending tens of millions for brick-and-mortar research facilities in places like China and India.

What this all adds up to is medical device organizations need to evaluate expansion of their clinical programs into emerging markets to cut costs and boost sales. Large countries like China and India are now requiring local clinical trials to win regulatory approvals to market products in those countries.

A study from Best Practices, LLC, Clinical Affairs Excellence: Benchmarking Clinical Trial Strategies to Ensure Medical Device Success in a Global Marketplace, delivers hard-to-find external benchmarks on medical device clinical programs' presence in emerging markets, activities outsourced, staffing and budgets.

This study analyzes factors associated with outsourcing clinical trial activities – including cost, staffing and quality – to help clinical leaders evaluate their organization's approach to outsourcing relative to peers. Through the qualitative (four executive interviews were done as part of this study) and quantitative data in this study, clinical leaders can formulate a strategic approach for engaging emerging regions in clinical affairs activities.

Critical outsourcing questions addressed in this survey include:

  • What are the regions where medical device companies are conducting clinical trials and the percent of patients recruited annually f
    '/>"/>

Advertisement
Advertisement